Mary Kay Fenton Talaris Therapeutics, Inc. (TALS) insider trading activity

TALS Quotes by TradingView

Mary Kay Fenton is Chief Financial Officer of Talaris Therapeutics, Inc.. Currently has a direct ownership of 68,054 shares of TALS, which is worth approximately $185,106. The most recent transaction as insider was on Jul 03, 2023, when has been sold 12,946 shares (Common Stock) at a price of $3.08 per share, resulting in proceeds of $39,873. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.1K
0% 3M change
0% 12M change
Total Value Held $185,106

Mary Kay Fenton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 03 2023
SELL
Payment of exercise price or tax liability
$39,873 $3.08 p/Share
12,946 Reduced 15.98%
68,054 Common Stock
Sep 10 2022
BUY
Grant, award, or other acquisition
-
80,000 Added 49.69%
81,000 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$13,000 $13.0 p/Share
1,000 Added 50.0%
1,000 Common Stock

Also insider at

ONCR
Oncorus, Inc. Healthcare
Director
CGEM
Cullinan Oncology, Inc. Healthcare
Chief Financial Officer
MKF

Mary Kay Fenton

Chief Financial Officer
Wellesley, MA

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TALS